Device Trial Radar · NCT07875985
Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 1, 2026
Primary completion
Nov 1, 2027
Study completion Dec 1, 2027
Sponsor
- Lead sponsor
- Shaare Zedek Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 15, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to identify predictors of successful removal of benign intrauterine pathology using a mini-resectoscope during office operative hysteroscopy without anesthesia in adult women with suspected or diagnosed endometrial polyps or retained products of conception up to 2.5 cm in size. The main questions it aims to answer are: * Which demographic, gynecologic, clinical, and hysteroscopic factors are associated with successful completion of office operative hysteroscopy using a mini-resectoscope without anesthesia? * Which factors are associated with severe pain during the procedure, defined as a Visual Analog Scale (VAS) score greater than 7? * Is prolonged procedure duration (\>3 minutes) associated with higher intraoperative pain scores? * Are there differences in success rates between procedures performed for endometrial polyps versus retained products of conception? Participants will: * Undergo office operative hysteroscopy without anesthesia using the Miniresectoscope device for removal of endometrial polyps or retained products of conception. * Provide demographic, obstetric, gynecologic, and medical history information before the procedure. * Have intraoperative hysteroscopic and surgical characteristics recorded, including cervical stenosis, uterine orientation, lesion size and location, lesion morphology, and procedure duration. * Complete pain assessments using the Visual Analog Scale (VAS) during the procedure and 5 minutes after the procedure. * Be evaluated for procedural success, defined as complete removal of the intrauterine pathology.
Conditions
- Retained Products of Conception
- Hysteroscopy
- Endometrial Polyp Benign
- Endometrial Polyp
- Endometrial Polyps
- Retained Products After Miscarriage
- Retained Products of Conception Post Abortion
- Retained Product of Conception After First Trimester Medical Abortion
- Retained Placenta
- Retained Product of Pregnancy
- Hysteroscopy Surgery
- Hysteroscopy Technique
Interventions
Office Operative Hysteroscopy Using the Karl Storz Mini-Resectoscope Without AnesthesiaDevice
Office operative hysteroscopy performed without anesthesia using the Karl Storz Mini-Resectoscope system (outer diameter approximately 5.5 mm) for hysteroscopic removal of benign intrauterine pathology, including endometrial polyps and retained products of conception up to 2.5 cm in size. Procedures are performed in an outpatient hysteroscopy clinic using a see-and-treat approach without routine cervical dilation, sedation, or general anesthesia. Intraoperative procedural characteristics, procedure duration, procedural completion, and patient-reported pain scores using the Visual Analog Scale (VAS) are prospectively recorded.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Complete Removal of Intrauterine Pathology During Office Operative Hysteroscopy Using the Karl Storz Mini-Resectoscope Without AnesthesiaTime frame: During the procedure
- Comparison of Rates of Incomplete Office Operative Hysteroscopy Using the Karl Storz Mini-Resectoscope According to Patient's CharacteristicsTime frame: During the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Gynecology, Shaare Zedek Medical Center
Jerusalem, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.